Mitochondrial DNA haplogroup H as a risk factor for idiopathic dilated cardiomyopathy in Spanish population

Mitochondrion

Volumn 13, Issue 4, 2013, Pages 263-268

  Fernandez Caggiano M ^a   Barallobre Barreiro, J ^a   Rego Perez I ^a   Crespo Leiro, M G ^a,b   Paniagua, M J ^a,b   Grille Z ^a,b   Blanco, F J ^a   Domenech N ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Idiopathic dilated cardiomyopathy; Mitochondrial haplogroups; Oxidative stress; Reactive oxygen species; Single nucleotide polymorphisms

Indexed keywords

MITOCHONDRIAL DNA;

AGED; ALLELE; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; HAPLOGROUP H; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CARDIOMYOPATHY, DILATED; DNA, MITOCHONDRIAL; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SPAIN;

EID: 84876403131     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2013.03.005     Document Type: Article

References (52)

1. Baig M.K., Goldman J.H., Caforio A.L., Coonar A.S., Keeling P.J., McKenna W.J. Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. J. Am. Coll. Cardiol. 1998, 31:195-201.
2. Beckstead W.A., Ebbert M.T., Rowe M.J., McClell Evolutionary pressure on mitochondrial cytochrome b is consistent with a role of CytbI7T affecting longevity during caloric restriction. PLoS One 2009, 4(6):e5836.
3. Benn M., Schwartz M., Nordestgaard B.G., Tybjaerg-Hansen A. Mitochondrial haplogroups: ischemic cardiovascular disease, other diseases, mortality, and longevity in the general population. Circulation 2008, 117(19):2492-2501.
4. Burton K.P., McCord J.M., Ghai G. Myocardial alterations due to free-radical generation. Am. J. Physiol. 1984, 246(6 Pt 2):H776-H783.
5. Cai X.Y., Wang X.F., Li S.L., Qian J., Qian D.G., Chen F., Yang Y.J., Yuan Z.Y., Xu J., Bai Y., Yu S.Z., Jin L. Association of mitochondrial DNA haplogroups with exceptional longevity in a Chinese population. PLoS One 2009, 4(7). (29).
6. Canton M., Menazza S., Sheeran F.L., Polverino de Laureto P., Di Lisa F., Pepe S.J. Oxidation of myofibrillar proteins in human heart failure. J. Am. Coll. Cardiol. 2011, 57(3):300-309.
7. Cappola T.P., Kass D.A., Nelson G.S., Berger R.D., Rosas G.O., Kobeissi Z.A., Marbán E., Hare J.M. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 2001, 104(20):2407-2411.
8. Castro M.G., Huerta C., Reguero J.R., Soto M.I., Doménech E., Alvarez V., Gómez-Zaera M., Nunes V., González P., Corao A., Coto E. Mitochondrial DNA haplogroups in Spanish patients with hypertrophic cardiomyopathy. Int. J. Cardiol. 2006, 112(2):202-206.
9. Cesselli D., Jakoniuk I., Barlucchi L., Beltrami A.P., Hintze T.H., Nadal-Ginard B., Kajstura J., Leri A., Anversa P. Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ. Res. 2001, 89(3):279-286.
10. Chinnery P.F., Elliott H.R., Syed A., Rothwell P.M. Mitochondrial DNA haplogroups and risk of transient ischaemic attack and ischaemic stroke: a genetic association study. Lancet Neurol. 2010, 9(5):498-503.
11. DiMauro S., Schon E.A. Mitochondrial respiratory-chain diseases. N. Engl. J. Med. 2003, 348:2656-2668.
12. Fang H., Shen L., Chen T., He J., Ding Z., Wei J., Qu J., Chen G., Lu J., Bai Y. Cancer type-specific modulation of mitochondrial haplogroups in breast, colorectal and thyroid cancer. BMC Cancer 2010, 10:421.
13. Fernández-Caggiano M., Barallobre-Barreiro J., Rego-Pérez I., Crespo-Leiro M.G., Paniagua M.J., Grillé Z., Blanco F.J., Doménech N. Mitochondrial haplogroups H and J: risk and protective factors for ischemic cardiomyopathy. PLoS One 2012, 7(8):e44128.
14. Gallardo M.E., García-Pavía P., Chamorro R., Vázquez M.E., Gómez-Bueno M., Millán I., Almoguera B., Domingo V., Segovia J., Vilches C., Alonso-Pulpón L., Garesse R., Bornstein B. Mitochondrial haplogroups associated with end-stage heart failure and coronary allograft vasculopathy in heart transplant patients. Eur. Heart J. 2012, 33(3):346-353.
15. Gupta M., Singal P.K. Time course of structure, function, and metabolic changes due to an exogenous source of oxygen metabolites in rat heart. Can. J. Physiol. Pharmacol. 1989, 67(12):1549-1559.
16. Herrnstadt C., Howell N. An evolutionary perspective on pathogenic mtDNA mutations: haplogroup associations of clinical disorders. Mitochondrion 2004, 4:791-798.
17. Hill M.F., Singal P.K. Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am. J. Pathol. 1996, 148:291-300.
18. Kaneko M., Matsumoto Y., Hayashi H., Kobayashi A., Yamazaki N. Oxygen free radicals and calcium homeostasis in the heart. Rev. Mol. Cell. Biochem. 1994, 135(1):99-108.
19. Kato Y., Iwase M., Ichihara S., Kanazawa H., Hashimoto K., Noda A., Nagata K., Koike Y., Yokota M. Beneficial effects of growth hormone-releasing peptide on myocardial oxidative stress and left ventricular dysfunction in dilated cardiomyopathic hamsters. Circ. J. 2010, 74(1):163-170.
20. Kawakami S., Matsuda A., Sunagawa T., Noda Y., Kaneko T., Tahara S., Hiraumi Y., Adachi S., Matsui H., Ando K., Fujita T., Maruyama N., Shirasawa T., Shimizu T. Antioxidant, EUK-8, prevents murine dilated cardiomyopathy. Circ. J. 2009, 73(11):2125-2134.
21. Kinugawa S., Tsutsui H., Hayashidani S., Ide T., Suematsu N., Satoh S., Utsumi H., Takeshita A. Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress. Circ. Res. 2000, 87:392-398.
22. Kofler B., Mueller E.E., Eder W., Stanger O., Maier R., Weger M., Haas A., Winker R., Schmut O., Paulweber B., Iglseder B., Renner W., Wiesbauer M., Aigner I., Santic D., Zimmermann F.A., Mayr J.A., Sperl W. Mitochondrial DNA haplogroup T is associated with coronary artery disease and diabetic retinopathy: a case control study. BMC Med. Genet. 2009, 21(10):35.
23. Li Y.Y., Maisch B., Rose M.L., Hengstenberg C. Point mutations in mitochondrial DNA of patients with dilated cardiomyopathy. J. Mol. Cell. Cardiol. 1997, 29(10):2699-2709.
24. Li X.Y., Guo Y.B., Su M., Cheng L., Lu Z.H., Tian D.P. Association of mitochondrial haplogroup D and risk of esophageal cancer in Taihang Mountain and Chaoshan areas in China. Mitochondrion 2011, 11(1):27-32.
25. Liu M., Liu H., Dudley S.C. Reactive oxygen species originating from mitochondria regulate the cardiac sodium channel. Circ. Res. 2010, 107(8):967-974.
26. Mahjoub S., Sternberg D., Boussaada R., Filaut S., Gmira F., Mechmech R., Jardel C., Arab S.B. A novel mitochondrial DNA tRNAIle (m.4322dupC) mutation associated with idiopathic dilated cardiomyopathy. Diagn. Mol. Pathol. 2007, 16:238-242.
27. Mancuso M., Conforti F.L., Rocchi A., Tessitore A., Muglia M., Tedeschi G., Panza D., Monsurrò M., Sola P., Mandrioli J., Choub A., DelCorona A., Manca M.L., Mazzei R., Sprovieri T., Filosto M., Salviati A., Valentino P., Bono F., Caracciolo M., Simone I.L., La Bella V., Majorana G., Siciliano G., Murri L., Quattrone A. Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis?. Neurosci. Lett. 2004, 371(2-3):158-162.
28. Marcuello A., Martínez-Redondo D., Dahmani Y., Casajús J.A., Ara I., Dahmani Y., Montoya J., Ruiz-Pesini E., López-Pérez M.J., Díez-Sánchez C. Human mitochondrial variants influence on oxygen consumption. Mitochondrion 2009, 9(1):27-30.
29. Marin-Garcia J., Goldenthal M.J., Ananthakrishnan R., Pierpont M.E. The complete sequence of mtDNA genes in idiopathic dilated cardiomyopathy shows novel missense and tRNA mutations. J. Card. Fail. 2000, 6:321-329.
30. Martínez-Redondo D., Marcuello A., Casajús J.A., Ara I., Dahmani Y., Montoya J., Ruiz-Pesini E., López-Pérez M.J., Díez-Sánchez C. Human mitochondrial haplogroup H: the highest VO(2max) consumer - is it a paradox?. Mitochondrion 2009, 10(2):102-107.
31. Mestroni L., Krajinovic M., Severini G.M., Pinamonti B., Di Lenarda A., Giacca M., Falaschi A., Camerini F. Familial dilated cardiomyopathy. Br. Heart J. 1994, 72:S35-S41.
32. Michels V.V., Moll P.P., Miller F.A., Tajik A.J., Chu J.S., Driscoll D.J., Burnett J.C., Rodeheffer R.J., Chesebro J.H., Tazelaar H.D. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N. Engl. J. Med. 1992, 326:77-82.
33. Mishmar D., Ruiz-Pesini E., Golik P., Macaulay V., Clark A.G., Hosseini S., Brandon M., Easley K., Chen E., Brown M.D., Sukernik R.I., Olckers A., Wallace D.C. Natural selection shaped regional mtDNA variation in humans. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:171-176.
34. Nishigaki Y., Yamada Y., Fuku N., Matsuo H., Segawa T., Watanabe S., Kato K., Yokoi K., Yamaguchi S., Nozawa Y., Tanaka M. Mitochondrial haplogroup N9b is protective against myocardial infarction in Japanese males. Hum. Genet. 2007, 120(6):827-836.
35. Nishioka K., Nakagawa K., Umemura T., Jitsuiki D., Ueda K., Goto C., Chayama K., Yoshizumi M., Higashi Y. Carvedilol improves endothelium-dependent vasodilation in patients with dilated cardiomyopathy. Heart 2007, 93(2):247-248.
36. Palacín M., Alvarez V., Martín M., Díaz M., Corao A.I., Alonso B., Díaz-Molina B., Lozano I., Avanzas P., Morís C., Reguero J.R., Rodríguez I., López-Larrea C., Cannata-Andía J., Batalla A., Ruiz-Ortega M., Martínez-Camblor P., Coto E. Mitochondrial DNA and TFAM gene variation in early-onset myocardial infarction: evidence for an association to haplogroup H. Mitochondrion 2011, 11(1):176-181.
37. Pello R., Martín M.A., Carelli V., Nijtmans L.G., Achilli A., Pala M., Torroni A., Gómez-Durán A., Ruiz-Pesini E., Martinuzzi A., Smeitink J.A., Arenas J., Ugalde C. Mitochondrial DNA background modulates the assembly kinetics of OXPHOS complexes in a cellular model of mitochondrial disease. Hum. Mol. Genet. 2008, 17(24):4001-4011.
38. Radford M.J., Arnold J.M., Bennett S.J., Cinquegrani M.P., Cleland J.G., Havranek E.P., Heidenreich P.A., Rutherford J.D., Spertus J.A., Stevenson L.W., Goff D.C., Grover F.L., Malenka D.J., Peterson E.D., Redberg R.F., American College of Cardiology, American Heart Association Task Force on Clinical Data Standards, American College of Chest Physicians, International Society for Heart and Lung Transplantation, Heart Failure Society of America ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Heart Failure Clinical Data Standards): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Failure Society of America. Circulation 2005, 112(12):1888-1916.
39. Rampersaud E., Kinnamon D.D., Hamilton K., Khuri S., Hershberger R.E., Martin E.R. Common susceptibility variants examined for association with dilated cardiomyopathy. Ann. Hum. Genet. 2010, 74(2):110-116.
40. Rego-Pérez I., Fernández-Moreno M., Fernández-López C., Arenas J., Blanco F.J. Mitochondrial DNA haplogroups: role in the prevalence and severity of knee osteoarthritis. Arthritis Rheum. 2008, 58(8):2387-2396.
41. Rego-Pérez I., Fernández-Moreno M., Fernández-López C., Gómez-Reino J.J., González A., Arenas J., Blanco F.J. Role of European mitochondrial DNA haplogroups in the prevalence of hip osteoarthritis in Galicia, Northern Spain. Ann. Rheum. Dis. 2010, 69(1):210-213.
42. Rosa A., Fonseca B.V., Krug T., Manso H., Gouveia L., Albergaria I., Gaspar G., Correia M., Viana-Baptista M., Simões R.M., Pinto A.N., Taipa R., Ferreira C., Fontes J.R., Silva M.R., Gabriel J.P., Matos I., Lopes G., Ferro J.M., Vicente A.M., Oliveira S.A. Mitochondrial haplogroup H1 is protective for ischemic stroke in Portuguese patients. BMC Med. Genet. 2008, 1(9):57.
43. Ruiz-Pesini E., Mishmar D., Brandom M., Procaccio V., Wallace D.C. Effects of purifying and adaptative selection on regional variation in human mtDNA. Science 2004, 303:223-226.
44. Santorelli F.M., Tanji K., Manta P., Casali C., Krishna S., Hays A.P., Mancini D.M., DiMauro S., Hirano M. Maternally inherited cardiomyopathy: an atypical presentation of the mtDNA 12S rRNA gene A1555G mutation. Am. J. Hum. Genet. 1999, 64:295-300.
45. Santoro A., Balbi V., Balducci E., Pirazzini C., Rosini F., Tavano F., Achilli A., Siviero P., Minicuci N., Bellavista E., Mishto M., Salvioli S., Marchegiani F., Cardelli M., Olivieri F., Nacmias B., Chiamenti A.M., Benussi L., Ghidoni R., Rose G., Gabelli C., Binetti G., Sorbi S., Crepaldi G., Passarino G., Torroni A., Franceschi C. Evidence for sub-haplogroup h5 of mitochondrial DNA as a risk factor for late onset Alzheimer's disease. PLoS One 2010, 5(8):e12037.
46. Shah A., Passacquale G., Gkaliagkousi E., Ritter J., Ferro A. Platelet nitric oxide signalling in heart failure: role of oxidative stress. Cardiovasc. Res. 2011, 91(4):625-631.
47. Torroni A., Huoponen K., Francalacci P., Petrozzi M., Morelli L., Scozzari R., Obinu D., Savontaus M.L., Wallace D.C. Classification of European mtDNAs from an analysis of three European populations. Genetics 1996, 144(4):1835-1850.
48. van der Walt J.M., Nicodemus K.K., Martin E.R., Scott W.K., Nance M.A., Watts R.L., Hubble J.P., Haines J.L., Koller W.C., Lyons K., Pahwa R., Stern M.B., Colcher A., Hiner B.C., Jankovic J., Ondo W.G., Allen F.H., Goetz C.G., Small G.W., Mastaglia F., Stajich J.M., McLaurin A.C., Middleton L.T., Scott B.L., Schmechel D.E., Pericak-Vance M.A., Vance J.M. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am. J. Hum. Genet. 2003, 72(4):804-811.
49. van der Walt J.M., Dementieva Y.A., Martin E.R., Scott W.K., Nicodemus K.K., Kroner C.C., Welsh-Bohmer K.A., Saunders A.M., Roses A.D., Small G.W., Schmechel D.E., Murali Doraiswamy P., Gilbert J.R., Haines J.L., Vance J.M., Pericak-Vance M.A. Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neurosci. Lett. 2004, 365(1):28-32.
50. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 2005, 39:359-407.
51. Yücel D., Aydoǧdu S., Cehreli S., Saydam G., Canatan H., Seneş M., Ciǧdem Topkaya B., Nebioǧlu S. Increased oxidative stress in dilated cardiomyopathic heart failure. Clin. Chem. 1998, 44(1):148-154.
52. Yücel D., Aydoǧdu S., Seneş M., Topkaya B.C., Nebioǧlu S. Evidence of increased oxidative stress by simple measurements in patients with dilated cardiomyopathy. Scand. J. Clin. Lab. Invest. 2002, 62(6):463-468.